Back to Journals » Patient Preference and Adherence » Volume 1

Drug use and barriers to and facilitators of drug treatment for homeless youth

Authors Adeline Nyamathi, Angela Hudson, Malaika Mutere, Ashley Christiani, Jeff Sweat, Kamala Nyamathi, Theresa Broms

Published 24 October 2007 Volume 2007:1 Pages 1—8

Adeline Nyamathi1, Angela Hudson1, Malaika Mutere1, Ashley Christiani2, Jeff Sweat3, Kamala Nyamathi1, Theresa Broms1

1School of Nursing, 2David Geffen School of Medicine, 3Department of Sociology, University of California, Los Angeles, CA, USA

Abstract: In the United States, homeless youth are becoming increasingly entrenched in problem substance use, including high prevalence of alcohol abuse and injection use. A total of 54 substance-using homeless youth (18–25 years) participated in focus groups in order to provide their perspectives on barriers to and facilitators of seeking treatment. Participants were recruited from shelters in Hollywood, CA, and from a street-based, drop-in site in Santa Monica, CA. Participants identified personal barriers to treatment, but reported that facilitators of treatment tended to be more systematic. Homeless youth used and abused substances to dim the psychological effects of living on the streets. They appreciated programs that facilitated treatment and rehabilitation such as mentoring, support groups, and alternative choices to substance use. Implications point to the need for further development and research on culturally-appropriate, age-sensitive programs for homeless youth. The experiences of these youth underscore the need for strategic interventions.

Keywords: homeless, substance use, Los Angeles

Download Article [PDF] 

Readers of this article also read:

Paclitaxel attenuates renal interstitial fibroblast activation and interstitial fibrosis by inhibiting STAT3 signaling

Zhang L, Xu X, Yang R, Chen J, Wang S, Yang JQ, Xiang X, He Z, Zhao Y, Dong Z, Zhang D

Drug Design, Development and Therapy 2015, 9:2139-2148

Published Date: 15 April 2015

Promoting endothelial recovery and reducing neointimal hyperplasia using sequential-like release of acetylsalicylic acid and paclitaxel-loaded biodegradable stents

Lee CH, Yu CY, Chang SH, Hung KC, Liu SJ, Wang CJ, Hsu MY, Hsieh IC, Chen WJ, Ko YS, Wen MS

International Journal of Nanomedicine 2014, 9:4117-4133

Published Date: 27 August 2014

Fabrication of nanoadjuvant with poly-e-caprolactone (PCL) for developing a single-shot vaccine providing prolonged immunity

Prashant CK, Bhat M, Srivastava SK, Saxena A, Kumar M, Singh A, Samim M, Ahmad FJ, Dinda AK

International Journal of Nanomedicine 2014, 9:937-950

Published Date: 12 February 2014

Suturing techniques and postoperative management in penetrating keratoplasty in the United Kingdom

Lee RM, Lam FC, Georgiou T, Paul B, Then KY, Mavrikakis I, Avadhanam VS, Liu CS

Clinical Ophthalmology 2012, 6:1335-1340

Published Date: 15 August 2012

Optical imaging to trace near infrared fluorescent zinc oxide nanoparticles following oral exposure

Lee CM, Jeong HJ, Yun KN, Kim DW, Sohn MH, Lee JK, Jeong J, Lim ST

International Journal of Nanomedicine 2012, 7:3203-3209

Published Date: 27 June 2012

Patient’s compliance with allergen immunotherapy

Cristoforo Incorvaia, Marina Mauro, Erminia Ridolo, Paola Puccinelli, Massimiliano Liuzzo, et al

Patient Preference and Adherence 2008, 2:247-251

Published Date: 15 September 2008

Cognitive deficits and functional outcome in schizophrenia

Christopher R Bowie, Philip D Harvey

Neuropsychiatric Disease and Treatment 2006, 2:531-536

Published Date: 15 December 2006